Breaking News

PacificGMP Makes Two Senior Appointments

January 29, 2016

Will support the growth that PacificGMP has continued to make since joining Abzena

The U.S. biomanufacturing subsidiary of Abzena, PacificGMP, has made two senior appointments to support its growth.

“PacificGMP has attracted two very experienced individuals from leading companies in the sector. These appointments will support the growth that PacificGMP has continued to make since joining Abzena and we look forward to their valuable contribution.”

PacificGMP is a contract process development and manufacturing company based in San Diego, acquired by Abzena in September 2015.

Jon Strauss has been appointed director of manufacturing at PacificGMP. He joins from Genentech where, for the last five years, he was involved in all aspects of the manufacture of biopharmaceuticals. He was previously a senior scientist at CMC Biologics, having also worked at Momenta and Bayer Healthcare.

Mike Faughnan has been appointed to the new role of senior director of business development, PacificGMP. He joins from Lonza Biologics where he spent more than five years as a manager in the sales and business development group. His previous roles include contract manufacturing organizations, Eden Biodesign and Cytovance Biologics.

Related Contract Manufacturing:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks